1V1K: Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino Pyrimidine Cdk4 Inhibitor
reference: Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimisation of substituted 4,6-bis anilino pyrimidines., Beattie JF, Breault GA, Ellston RP, Green S, Jewsbury PJ, Midgley CJ, Naven RT, Minshull CA, Pauptit RA, Tucker JA, Pease JE, Bioorg Med Chem Lett. 2003 Sep 15;13(18):2955-60. PMID: 12941311

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).